Baolingbao Biology Co.,Ltd. (SHE:002286)

Baolingbao Biology Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	270.56	254.95	242.74	375.95	585.44	485.25
Trading Asset Securities	-	-	-	-	106.67	-
Cash & Short-Term Investments	270.56	254.95	242.74	375.95	692.11	485.25
Cash Growth	15.75%	5.03%	-35.43%	-45.68%	42.63%	16.65%
Accounts Receivable	289.3	245.79	241.99	238.48	284.29	206.6
Other Receivables	4.89	8.06	19.25	12.32	19	83.52
Receivables	294.19	253.85	261.24	250.8	303.29	290.12
Inventory	338.32	288.71	278.58	335.39	285.09	216.36
Prepaid Expenses	-	-	-	-	0.76	1.52
Other Current Assets	32.88	12.71	3.31	33.64	33.63	14.91
Total Current Assets	935.95	810.22	785.87	995.78	1,315	1,008
Property, Plant & Equipment	1,436	1,454	1,433	1,532	1,286	1,224
Long-Term Investments	235.51	246.92	286.16	323.53	268.14	233.6
Other Intangible Assets	115.89	117.5	121.28	125.07	129.27	133.6
Long-Term Deferred Tax Assets	11.42	10.31	5.58	4.16	3.32	2.17
Long-Term Deferred Charges	28.62	22.38	20.42	18.68	12.14	5.48
Other Long-Term Assets	16.03	12.21	6.91	6.65	14.89	8.35
Total Assets	2,780	2,674	2,659	3,006	3,029	2,616
Accounts Payable	171.22	213.11	237.56	314.16	634.38	662.9
Accrued Expenses	43.88	39.12	32.84	38.54	42.22	28.1
Short-Term Debt	294.86	260.19	209.81	244.17	369.18	235.34
Current Portion of Long-Term Debt	-	9.51	42	85.9	0.5	-
Current Portion of Leases	-	1.15	3.38	5.07	4.43	-
Current Income Taxes Payable	-	5.64	2.66	4.83	10.87	1.83
Current Unearned Revenue	13.99	33.45	20.3	42	29.35	20.3
Other Current Liabilities	73.05	13.94	27.92	24.79	28.92	7.93
Total Current Liabilities	596.99	576.1	576.47	759.46	1,120	956.41
Long-Term Debt	10.79	10.79	48.69	178.39	30.32	10.79
Long-Term Leases	2.19	1.17	0.25	3.07	7.45	-
Long-Term Unearned Revenue	45.94	43.66	49.14	60.07	58.11	49.17
Long-Term Deferred Tax Liabilities	0.64	0.71	0.85	0.8	0.04	-
Total Liabilities	656.56	632.44	675.41	1,002	1,216	1,016
Common Stock	380.12	369.77	370.77	371.81	371.91	369.26
Additional Paid-In Capital	845.8	812.45	818.51	830.64	821.56	800.86
Retained Earnings	882.53	812.67	743.89	719.52	608.66	429.24
Treasury Stock	-40.57	-	-7.06	-14.4	-18.7	-
Comprehensive Income & Other	55.14	46.64	57.38	96.77	29.8	0.01
Total Common Equity	2,123	2,042	1,983	2,004	1,813	1,599
Shareholders' Equity	2,123	2,042	1,983	2,004	1,813	1,599
Total Liabilities & Equity	2,780	2,674	2,659	3,006	3,029	2,616
Total Debt	307.84	282.81	304.13	516.6	411.88	246.13
Net Cash (Debt)	-37.28	-27.86	-61.39	-140.65	280.23	239.12
Net Cash Growth	-	-	-	-	17.19%	-
Net Cash Per Share	-0.10	-0.08	-0.17	-0.38	0.75	0.67
Filing Date Shares Outstanding	381.69	369.77	370.77	371.81	371.91	369.26
Total Common Shares Outstanding	381.69	369.77	370.77	371.81	371.91	369.26
Working Capital	338.96	234.12	209.39	236.32	195.05	51.75
Book Value Per Share	5.56	5.52	5.35	5.39	4.88	4.33
Tangible Book Value	2,007	1,924	1,862	1,879	1,684	1,466
Tangible Book Value Per Share	5.26	5.20	5.02	5.05	4.53	3.97
Buildings	-	771.66	770.06	-	-	648.03
Machinery	-	1,476	1,559	-	-	1,048
Construction In Progress	-	115.74	2.57	40.48	52.85	137.41

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.